CMS still reviewing comments on Part B model

Media reports that CMS has delayed implementation of a proposed Medicare Part B drug payment model are incorrect, CMS spokesperson Aaron Albright told BioCentury Monday. "We have not announced a change in timing and we continue to review comments," he said. ...